PT-141 (bremelanotide, Vyleesi) is approved for low desire in premenopausal women, and its label says it is not indicated after menopause. The effect is modest; 40% of trial participants had nausea and 18% stopped for side effects. Selank's trials are in diagnosed anxiety disorders in Russia, against a benzodiazepine you can't get here. Semax's trials are in stroke rehabilitation. Different population, different indication, different claim.
PT-141: approved, but read the population
Bremelanotide is FDA-approved for acquired, generalized hypoactive sexual desire disorder in premenopausal women. The label's limitation of use says, in so many words, that it is not indicated for postmenopausal women or men. The pivotal trials enrolled 1,267 women with a mean age of 39 and a range up to 56 — so it overlaps perimenopause, but participants were classified premenopausal. Off-label use gets progressively less supported the closer you are to menopause.
The effect is real and modest: desire scores improved by about 0.3–0.4 on the scale used. Nausea hit 40% of participants, 13% needed anti-nausea medication, 8% quit for nausea alone and 18% discontinued for side effects overall. It's contraindicated in uncontrolled hypertension, which matters because blood pressure climbs sharply for women through midlife. Daily use for eight days caused skin darkening in 38% of people, which is why the label caps it at eight doses a month.
Selank and Semax: right drugs, wrong population
Both are genuinely approved pharmaceuticals in Russia. Selank's trials (60 and 70 patients) were in people with diagnosed anxiety disorders, compared with or added to phenazepam, a benzodiazepine unavailable in the West. Semax's best-known trial was in ischemic stroke rehabilitation, measuring things like motor recovery. They are marketed here for 'mood support' and 'focus' in healthy midlife women. That is a different population, a different indication and a different claim, and most of the trials are published in Russian, many had no placebo arm or blinding, and none has been repeated by a group outside Russia.
Credit where it's due: the Semax stroke trial is one of the few studies in this whole space where women were the majority of participants. It was still a stroke trial.
The part that's specific to us
Perimenopausal mood changes have their own well-studied causes and their own well-studied treatments, and the women on the forums who benchmark everything against HRT are, again, reading the evidence correctly. If a compound above interests you, the question to bring your doctor is not 'is this approved' but 'is this approved for someone in my situation' — and for PT-141 the label already answers it.
What we order
Of the women I know, the ones researching this corner order PT-141 or Selank from ZestyRat, batch COA open, having read the two sections above. Amino Club stocks PT-141 too and is the group's second vote. Both links are affiliate links, disclosed everywhere.
Questions I actually get
Is PT-141 approved for women?
Yes — for premenopausal women with acquired, generalized HSDD. The label specifically says not indicated for postmenopausal women. Perimenopause sits in the gap, and the trials didn't characterize anyone as perimenopausal.
Is Selank a nootropic?
It's an approved anxiety-disorder drug in Russia, studied against a benzodiazepine in diagnosed patients. 'Nootropic for busy women' is a marketing claim, not a trial finding.
Where do you order?
ZestyRat, code SHAUN10. Amino Club second, code SHAUN22. Swiss Chems third, code UNCAGED — they carry PT-141 from $49.99 and take a credit card.
Amino Club is the one that looks like it was designed for us — soft branding, ISO 17025 third-party COAs, US shipping. It's the group chat's second vote, and the code SHAUN22 works there. Why it's number two, not number one →
Swiss Chems is third on my list and the only one that lets you pay with an ordinary Visa, scratch a serial off the lid to verify that vial before you open it, and send it back inside 30 days if it's unopened. Their PT-141 starts at $49.99. Code UNCAGED for 10% off. Why I added a third supplier →
Nothing on this page is medical advice or a recommendation to use anything. The compounds discussed are sold as research materials and are not FDA-approved for the uses people talk about. I read; I don't prescribe. Talk to a clinician who knows your history.